Tang Capital Management »

Crispr Therapeutics shares owned by Tang Capital Management

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Tang Capital Management from 13F filings

Historical chart of Tang Capital Management investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Tang Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Tang Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $14M 215k 62.60
2023-06-30 $1.1M 20k 56.14
2022-12-31 $407k 10k 40.65
2022-09-30 $3.3M 50k 65.36